Expanded Access Program for OOS Obe-cel
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Autolus Study Director
Autolus Limited
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
Matthew UlricksonAvailable - City of Hope Phoenix
Phoenix, Arizona, United States
Aileen GoAvailable - City of Hope National Medical Center
Duarte, California, United States
Karamjeet SandhuAvailable - University of California San Diego Health (ucsd)
La Jolla, California, United States
Dmitrios TzachanisAvailable - Stanford University
Palo Alto, California, United States
Lori MufflyAvailable - University of California San Francisco (ucsf)
San Francisco, California, United States
Aaron LoganAvailable - Colorado Blood Cancer Institute
Denver, Colorado, United States
MigdadyAvailable - Orlando Health
Orlando, Florida, United States
Samer KhaledAvailable - Emory
Atlanta, Georgia, United States
langstonAvailable - University of Iowa
Iowa City, Iowa, United States
Umar FarooqAvailable - Kansas University Medical Center
Kansas City, Kansas, United States
Joseph McGuirkAvailable - University of Maryland Medical Center
Baltimore, Maryland, United States
Jean YaredAvailable - Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Daniel J De AngeloAvailable - Available
- Available
- Hackensack University Medical Center
Hackensack, New Jersey, United States
Michele DonatoAvailable - Memorial Sloan Kettering Cancer Center
New York, New York, United States
JaeHong ParkAvailable - Nyu-Langone
New York, New York, United States
Abdul HayAvailable - Cleveland Clinic
Cleveland, Ohio, United States
MolinaAvailable - the Ohio State University
Columbus, Ohio, United States
Marcos De LimaAvailable - Oregon Health and Science University
Portland, Oregon, United States
Hayes-LattinAvailable - University of Pennsylvania
Philadelphia, Pennsylvania, United States
Noelle FreyAvailable - Tristar Centennial Medical Center (scri)
Nashville, Tennessee, United States
BattiwallaAvailable - Vanderbilt University Medical Center
Nashville, Tennessee, United States
OluwoleAvailable - St. David'S South Austin Medical Center
Austin, Texas, United States
Aravind RamakrishnanAvailable - Baylor Scott & White Research Institute
Dallas, Texas, United States
Houston HolmesAvailable - Medical City Dallas
Dallas, Texas, United States
BhushanAvailable - Houston Methodist Hospital
Houston, Texas, United States
Shilpin ShahAvailable - Available
- Texas Transplant Institute
San Antonio, Texas, United States
CruzAvailable - Washington University School of Medicine
Seattle, Washington, United States
Armin GhobadiAvailable - Mcw Froedtert
Milwaukee, Wisconsin, United States
Guru MurthyAvailable
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- —
- Primary completion
- —
- Completion
- —
- Last update posted
- 27 Feb 2026
- Registered enrollment
- —
- Registry id
- NCT06799221
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.